An engineered nanopore identifies saccharides, amino acids, peptides and ribonucleotides

Summary

Nature Biotechnology reports on an engineered nanopore technology capable of identifying saccharides, amino acids, peptides, and ribonucleotides. This is a research development with no associated company, clinical trial, or regulatory catalyst.